Breakfast & Networking
8:00-8:45 am
Opening Remarks & Welcome Address
8:45-8:50 am
Cancer’s Breakthrough Year: Can Care Keep Pace?
8:50-9:50 Moderated by Rebecca Stern, PhD, SVP at Gabelli Funds
• Richard Barakat, MD, MBA (CBS ’14), Physician-in-Chief & Executive Director of Northwell Cancer Institute
• Alan Bash, MBA (CBS ’99), President of CARVYKTI® at Legend Biotech (Nasdaq: LEGN)
• Christophe Griolet, PharmD, MBA, VP & General Manager, US Commercial Organization at Kite, a Gilead Company (Nasdaq: GILD)
• Mohit Manrao, MBA, SVP, Head of US Oncology at AstraZeneca (NYSE: AZN)
Break
9:50-10:05 am
Drug Access in the Specialty and GLP-1 Era
10:05-11:05 Moderated by Daniel Barasa, MBA, Portfolio Manager at Gabelli Funds
• Natalie Bedford, SVP, US Pharmaceutical Distribution Services, McKesson (NYSE: MCK)
• Marko Blagojevic, PharmD, SVP, Pharmacy at Gravie
• Leonard Glass, MD, FACE, SVP, Cardiometabolic Health, Global Medical Affairs at Eli Lilly and Company (NYSE: LLY)
• Andy Schmeltz, Chief Commercial Officer, CSL (ASX: CSL) (retired)
Break
11:05-11:20 am
Leveraging AI to Improve Care Delivery
11:20-12:20 Moderated by Carri Chan, PhD, Cain Brothers and Company Professor of Healthcare Management, and Faculty Director at Columbia Business School
• Anil Jain, MD, Chief Innovation Officer, Provider Digital Transformation at Innovaccer
• Kevin Larsen, MD, SVP, Clinical Innovation at Optum (NYSE: UNH)
• Dave Ross, Chief Technology Officer at Teladoc Health (NYSE: TDOC)
• Paul Taheri, MD, MBA, Chief Medical Officer of InnovAge (Nasdaq: INNV)
